Gene · 10105
Papers2,346
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,346
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mitochondria-associated programmed cell death: elucidating prognostic biomarkers, immune checkpoints, and therapeutic avenues in multiple myeloma. | Front Immunol | 2024 | 39726602 | PubTator, text mining | PubMed |
| Phenotypes Associated With Polycystic Ovary Syndrome Risk Variants. | J Endocr Soc | 2024 | 39687684 | PubTator, text mining | PubMed |
| The adenine nucleotide translocase family underlies cardiac ischemia-reperfusion injury through the mitochondrial permeability pore independently of cyclophilin D. | Sci Adv | 2024 | 39661674 | PubTator, text mining | PubMed |
| Indirubin induces apoptosis in ovarian cancer cells via the mitochondrial pathway. | Am J Transl Res | 2024 | 39544767 | PubTator, text mining | PubMed |
| N-terminal cleavage of cyclophilin D boosts its ability to bind F-ATP synthase. | Commun Biol | 2024 | 39528709 | PubTator, text mining | PubMed |
| Unveiling dynamic hepatocyte plasticity in HepaRG cells with a dual CYP reporter system. | PLoS One | 2024 | 39527612 | PubTator, text mining | PubMed |
| SIRT3 differentially regulates lysine benzoylation from SIRT2 in mammalian cells. | iScience | 2024 | 39524354 | Swiss-Prot, curated | PubMed |
| A Comparison of Molecular Techniques for Improving the Methodology in the Laboratory of Pharmacogenetics. | Int J Mol Sci | 2024 | 39519058 | PubTator, text mining | PubMed |
| Phosphocreatine ameliorates hepatocellular apoptosis mediated by protecting mitochondrial damage in liver ischemia/reperfusion injury through inhibiting TLR4 and Agonizing Akt Pathway. | Tissue Cell | 2024 | 39486133 | PubTator, text mining | PubMed |
| Cyclophilin D plays a critical role in the survival of senescent cells. | EMBO J | 2024 | 39448884 | PubTator, text mining | PubMed |
| Key Genes Involved in the Beneficial Mechanism of Hyperbaric Oxygen for Glioblastoma and Predictive Indicators of Hyperbaric Oxygen Prolonging Survival in Glioblastoma Patients. | Curr Med Sci | 2024 | 39446287 | PubTator, text mining | PubMed |
| Cyclophilin D, regulator of the mitochondrial permeability transition, impacts bone development and fracture repair. | Bone | 2024 | 39299628 | PubTator, text mining | PubMed |
| Neutrophil PPIF exacerbates lung ischemia-reperfusion injury after lung transplantation by promoting calcium overload-induced neutrophil extracellular traps formation. | Int Immunopharmacol | 2024 | 39236457 | PubTator, text mining | PubMed |
| Genetic analysis from multiple cohorts implies causality between 2200 druggable genes, telomere length, and leukemia. | Comput Biol Med | 2024 | 39216403 | PubTator, text mining | PubMed |
| Mitochondrial permeability transition dictates mitochondrial maturation upon switch in cellular identity of hematopoietic precursors. | Commun Biol | 2024 | 39122870 | PubTator, text mining | PubMed |
| Peptidyl-prolyl isomerase F as a prognostic biomarker associated with immune infiltrates and mitophagy in lung adenocarcinoma. | Transl Lung Cancer Res | 2024 | 38973949 | PubTator, text mining | PubMed |
| Dissecting prostate Cancer: Single-Cell insight into Macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl Isomerase F. | Int Immunopharmacol | 2024 | 38959543 | PubTator, text mining | PubMed |
| Nynrin preserves hematopoietic stem cell function by inhibiting the mitochondrial permeability transition pore opening. | Cell Stem Cell | 2024 | 38955185 | PubTator, text mining | PubMed |
| Stellate Ganglion Block Attenuates LPS-Induced Acute Lung Injury by Activating Sirt3 Regulation of Oxidative Stress and Inflammation. | Biomedicines | 2024 | 38927355 | PubTator, text mining | PubMed |
| The role of mitochondrial genes in ischemia-reperfusion injury: A systematic review of experimental studies. | Mitochondrion | 2024 | 38848983 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10105/papers?page=5